Jun-ling Li
Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100000, China
Beijing, 100000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Simultaneous Integrated Dose Reduction Radiation Therapy Versus Conventional Fractionated Radiation Therapy With Chemotherapy for Limited-Stage Small Cell Lung Cancer in the Modern Treatment Era: A Phase 3, Randomized Clinical Trial (SDR-RT trial).
Journal: International journal of radiation oncology, biology, physics
Published: June 12, 2025
RANKL/PD-1 dual blockade demonstrates survival benefit for patients with advanced lung adenocarcinoma harboring KRAS mutations.
Journal: Cell reports. Medicine
Published: October 07, 2024
Patients with non‑small cell lung cancer with the exon 21 L858R mutation: From distinct mechanisms to epidermal growth factor receptor tyrosine kinase inhibitor treatments (Review).
Journal: Oncology letters
Published: July 16, 2024
Dacomitinib for Advanced Non-small Cell Lung Cancer Patients Harboring Major Uncommon EGFR Alterations: A Dual-Center, Single-Arm, Ambispective Cohort Study in China.
Journal: Frontiers in pharmacology
Published: April 13, 2022
Efficacy and safety of concomitant immunotherapy and denosumab in patients with advanced non-small cell lung cancer carrying bone metastases: A retrospective chart review.
Journal: Frontiers in immunology
Published: March 30, 2022
Efficacy of dacomitinib in patients with non-small cell lung cancer carrying complex EGFR mutations: a real-world study.
Journal: Journal of thoracic disease
Published: November 22, 2021
Survival and pretreatment prognostic factors for extensive-stage small cell lung cancer: A comprehensive analysis of 358 patients.
Journal: Thoracic cancer
Published: March 13, 2021
Changes and Influential Factors of Chemotherapy Usage for Non-Small Cell Lung Cancer Patients in China: A Multicenter 10-Year (2005-2014) Retrospective Study.
Journal: Cancer management and research
Published: March 13, 2020
Circular RNA profiling identified as a biomarker for predicting the efficacy of Gefitinib therapy for non-small cell lung cancer.
Journal: Journal of thoracic disease
Published: July 10, 2019
Depth of Response was Associated with Progression-Free Survival in Patients with Advanced Non-small Cell Lung Cancer treated with EGFR-TKI.
Journal: Journal of Cancer
Published: January 23, 2019
What are the clinical symptoms and physical signs for non-small cell lung cancer before diagnosis is made? A nation-wide multicenter 10-year retrospective study in China.
Journal: Cancer medicine
Published: December 09, 2018
Last Updated: 09/26/2026